June 26, 2023

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

Subscribe to Weekly Broadcasts

WEEKLY HIGHLIGHT

Cisplatin & Carboplatin Shortages


Read NRG Oncology Memo

NRG Oncology Summer Meeting Registration is Open!

Join us in celebrating our 10th anniversary at our Summer Meeting in Philadelphia from Thursday, July 20, 2023 - Saturday, July 22, 2023. Sessions will be held in-person and available via streaming unless noted. Additionally, there will be virtual-only sessions on Monday and Tuesday, July 17-18, 2023. Click here to Register Today

 

Hotel Reservation Deadline TODAY: June 26, 2023

The hotel reservation deadline for #NRG2023 has been extended through today, June 26th. Please make your hotel reservation here as soon as possible.

 

Summer Symposium - Rare Tumors: Ideas for Implementation of Novel Concepts.

Be sure to register for this informative event happening Thursday, July 20, 2023. 8am – 12pm ET. Presentations will focus on the design, implementation strategies, and progress in clinical trials involving rare tumors. The information presented will span novel clinical trial design with incorporation of novel statistical design and molecular profiling.

See flyer for more information

Social Media Ambassadors wanted for #NRG2023

Apply now to be a #NRG2023 Social Media Ambassador for the NRG Oncology Summer Meeting being held July 20-22, 2023, in Philadelphia! This is the 10th anniversary celebration of NRG Oncology, so what better way to raise your profile than to be posting on your Twitter and/or Instagram accounts about all things #NRG2023? If interested, please send an e-mail

(& please include your Twitter handle) to: communications@nrgoncology.org or

send us a DM on Twitter by July 10th.

Join us at the Barnes

NRG Oncology will host our 10th anniversary at the Barnes Foundation on Friday, July 21st from 6-8 PM. Transportation will be provided.

NRG Oncology Memo: Cisplatin & Carboplatin Shortages

Please review the memorandum (posted on the NRG Oncology website) for recommended strategies for enrolling participants in NRG trials involving Cisplatin and Carboplatin.

 

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Reminder: Actively Recruiting MALE Patients only Read More

 

2. BRAIN

NRG-BN009: An updated funding sheet is posted on CTSU.

 

3. CANCER PREVENTION & CONTROL

NRG-CC005/FORTE: New and revised patient-directed materials are now available under the CIRB tab on the CTSU website for NRG-CC005. Please see the memorandum posted on CTSU for more information about these materials.


NRG-CC005/FORTE: The patient study web page has been updated and is available on the NRG Oncology website.


4. GYNECOLOGIC

GOG-0210: Reminder: Biospecimens, biomarker data, clinical data, and epidemiologic data are available for request. Please visit the NRG Oncology website for more information on this important study with the overall goal of improving the outcome and/or quality of life for patients with endometrial cancer.

 

NRG-GY012: Nearing accrual. Accrual is currently at 285 of the planned 288 patients. Please plan accordingly and check CTSU before enrolling patients.

 

NRG-GY012 and NRG-GY023 – Reminder: BLOOD PRESSURE CUFF SUPPLY IS VERY LIMITED - Please be advised that VWR has a very limited supply of blood pressure cuffs at present. Please check your supplies on site for any overlooked cuffs prior to ordering. Thank you for your cooperation. 

 

NRG-GY020: Reminder that there are mandatory biospecimen submissions at recurrence. Please review protocol Section 10.5.1 and Appendix V for complete information.

 

Printing Biospecimen Transmittal PDFs on GYN Trials

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

 

5. HEAD & NECK

NRG-HN005: Sites in Canada only: The NOL and additional forms for amendment 3 are posted on CTSU. Please complete and submit the CTSI, Protocol signature page and IB signature page via the Regulatory submission portal.


NRG-HN008: Reminder -Please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important.

 

6. LUNG

NRG-LU008: Sites in Canada only: The NOL and additional forms for this study are posted on CTSU. Please complete and submit the CTSI, Protocol signature page and IB signature page via the Regulatory submission portal.


7. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, NRG-CC005, and NRG/SWOG S1914. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, July 12, 2023.

DRUG SAFETY AND INVESTIGATOR'S BROCHURE (IB) UPDATES

Drug Safety and Investigator’s Brochure updates have been issued for the following studies:

DRUG NAME

PROTOCOL

WEBSITE FOR

SAFETY REPORTS

INVESTIGATOR'S

BROCHURE (IB)*

Durvalumab

NRG-GY012

NRG-GY023

NRG-HN004

NRG-LU004

RTOG 1308


CTSU

CTSU

CTSU

NRG

CTSU



Ipilimumab

NRG-BN002

NRG-BN007

NRG-GY025

NRG-GU012

NRG-LU002


NRG

CTSU

NRG

CTSU

CTSU



Nivolumab

NRG-BN002

NRG-BN007

NRG-GY025

NRG-GU012

NRG-HN005

NRG-HN007

NRG-LU002


NRG

CTSU

NRG

CTSU

CTSU

CTSU

CTSU



Trastuzumab

NRG-GY026


X

*The current version of the Investigator Brochure Documents for Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI)-sponsored trials are available for access via the Cancer Therapy Evaluation Program (CTEP) Online Agent Order Processing (OAOP) website. Log-in using your Identity and Access Management (IAM) username and password credentials and provide the requested information to access the document.

 

Every site principal investigator is responsible for reviewing this document. The Investigator Brochure is for use by the site principal investigator and any study personnel under his/her supervision who need to know the contents for the conduct of a clinical trial, including Institutional Review Board(s) or Independent Ethics Committee(s).

Independence Day Holiday Closures

The NRG Oncology Operations Offices, Statistics and Data Management Centers (SDMCs), Biospecimen Banks, Baylor Serum Bank, and McKesson's Clinical Research Services will be closed on Tuesday, July 4, 2023 in observance of the Independence Day holiday. On Monday, July 3, 2023, the Philadelphia East Operations Center will be closed for the day and the Operations Office and Biospecimen Bank in Pittsburgh will close at 3pm ET. Please refer to the memo posted on CTSU for more information about these closures and shipping information for the banks.


Register Today: Social Determinants of Cancer Care ~ Lessons Learned and Future Directions

Symposium hosted by the NRG Oncology Health Disparities Committee - Research Implementation Special Interest Group



Social determinants of health play a critical role in cancer care delivery and ultimately cancer outcomes. Furthermore, underrepresented patients have a disproportionately greater burden of cancer, with often higher mortality rates across a wide spectrum of cancer types attributable to bearing more advanced stage and aggressive disease as well as difficulties in access to equitable care, particularly among racial and ethnic minorities, older adults, and rural populations. This symposium will address current challenges related to social determinants of health, cancer care delivery and outcomes that includes innovative interventions to address disparities.

This symposium is being held via Zoom on Friday, June 30, 2023, from 2-3:30pm EDT. Please view the flyer hereClick here to register.

PUBLICATIONS


Please note the following upcoming meeting and abstract submission deadlines


UPCOMING MEETINGS

ESMO World Congress on Gastrointestinal Cancer; Jun 28-Jul 1, 2023; Barcelona, Spain


UPCOMING ABSTRACT SUBMISSION DEADLINES

American Society for Radiation Oncology (ASTRO); Oct 1-4, 2023; Chicago, IL; LBA Jul 12, 2023


European Society of Gynaecological Oncology (ESGO); Sep 28-Oct 1, 2023; Istanbul, Turkey; LBA Aug 7, 2023


European Society for Medical Oncology (ESMO) Congress; Oct 20-24, 2023; Madrid, Spain; LBA Sep 14, 2023, 9pm CEST


International Gynecologic Cancer Society (IGCS); Nov 5-7, 2023; Seoul, South Korea; Abstract & Film; TiP LBA, Aug 21, 2023


International Society for Quality-of-Life Research (ISOQOL); Oct 18-21, 2023; Calgary, AB Canada; LBA Jul 7, 2023


San Antonio Breast Cancer Symposium (SABCS); Dec 5-9, 2023; meeting submission deadline Jul 10, 2023; LBA Sep 30, 2023, 11:59 PM CT



Society for NeuroOncology (SNO); Nov 15-19, 2023; Vancouver, Canada; LBA Sep 4, 2023, 5:00 PM EDT

 

Facebook  Twitter  Instagram  LinkedIn